KRO
Kronos Worldwide, Inc.
Chemicals - Specialty
Market Cap$811M
5Y Perf.-27.8%
Compare Stocks
5 / 10Try these comparisons:
Stock Comparison
KRO vs TROX vs VHI vs HUN vs CC
Revenue, margins, valuation, and 5-year total return — side by side.
TROX
Tronox Holdings plc
Chemicals
Market Cap$1.34B
5Y Perf.+26.7%
VHI
Valhi, Inc.
Chemicals
Market Cap$412M
5Y Perf.+54.6%
HUN
Huntsman Corporation
Chemicals
Market Cap$2.56B
5Y Perf.-18.8%
CC
The Chemours Company
Chemicals - Specialty
Market Cap$3.36B
5Y Perf.+70.9%
KRO vs TROX vs VHI vs HUN vs CC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | KRO | TROX | VHI | HUN | CC |
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals | Chemicals | Chemicals | Chemicals - Specialty |
| Market Cap | $811M | $1.34B | $412M | $2.56B | $3.36B |
| Revenue (TTM) | $1.88B | $2.92B | $2.10B | $5.69B | $5.82B |
| Net Income (TTM) | $-134M | $-359M | $-67M | $-324M | $-411M |
| Gross Margin | 10.1% | 5.8% | 13.3% | 12.9% | 15.1% |
| Operating Margin | -3.1% | -4.8% | -1.4% | -1.0% | -0.8% |
| Forward P/E | — | — | 4.2x | — | 15.5x |
| Total Debt | $577M | $3.59B | $612M | $2.73B | $4.58B |
| Cash & Equiv. | $37M | $211M | $223M | $429M | $672M |
KRO vs TROX vs VHI vs HUN vs CC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
KRO
TROX
VHI
HUN
CC
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Kronos Worldwide, I… (KRO) | 100 | 72.2 | -27.8% |
| Tronox Holdings plc (TROX) | 100 | 126.7 | +26.7% |
| Valhi, Inc. (VHI) | 100 | 154.6 | +54.6% |
| Huntsman Corporation (HUN) | 100 | 81.2 | -18.8% |
| The Chemours Company (CC) | 100 | 170.9 | +70.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: KRO vs TROX vs VHI vs HUN vs CC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: VHI leads in 4 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. The Chemours Company is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. HUN also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
KRO
Kronos Worldwide, Inc.
The Income Pick
KRO is the clearest fit if your priority is income & stability.
- Dividend streak 0 yrs, beta 1.57, yield 2.8%
Best for: income & stability
TROX
Tronox Holdings plc
The Income Angle
Among these 5 stocks, TROX doesn't own a clear edge in any measured category.
Best for: basic materials exposure
VHI
Valhi, Inc.
The Growth Play
VHI carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth -1.3%, EPS growth -153.3%, 3Y rev CAGR -2.2%
- Lower volatility, beta 1.06, Low D/E 44.8%, current ratio 2.80x
- Beta 1.06, yield 2.2%, current ratio 2.80x
- Lower P/E (4.2x vs 15.5x)
Best for: growth exposure and sleep-well-at-night
HUN
Huntsman Corporation
The Income Pick
HUN ranks third and is worth considering specifically for dividends.
- 5.7% yield, vs KRO's 2.8%
Best for: dividends
CC
The Chemours Company
The Long-Run Compounder
CC is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 219.7% 10Y total return vs KRO's 129.0%
- 0.4% revenue growth vs HUN's -5.8%
- +108.8% vs VHI's -16.0%
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | CC | 0.4% revenue growth vs HUN's -5.8% |
| Value | VHI | Lower P/E (4.2x vs 15.5x) |
| Quality / Margins | VHI | -3.2% margin vs TROX's -12.3% |
| Stability / Safety | VHI | Beta 1.06 vs TROX's 2.37, lower leverage |
| Dividends | HUN | 5.7% yield, vs KRO's 2.8% |
| Momentum (1Y) | CC | +108.8% vs VHI's -16.0% |
| Efficiency (ROA) | VHI | -3.3% ROA vs KRO's -9.4%, ROIC -0.0% vs -1.9% |
KRO vs TROX vs VHI vs HUN vs CC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2014
FY 2025
FY 2025
FY 2025
FY 2025
KRO vs TROX vs VHI vs HUN vs CC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLVHILAGGINGTROX
Who Leads Where
CC leads in 2 of 6 categories
VHI leads 2 • HUN leads 1 • KRO leads 0 • TROX leads 0 • 1 tied
Explore the data ↓TROXTronox Holdings plc
0leads
KROKronos Worldwide, Inc.
0leads
HUNHuntsman Corporation
1leads
CCThe Chemours Company
2leads
VHIValhi, Inc.
2leads
6 Total Categories
CATEGORYLEADERvs CCvs HUNMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
CC3/6
Valuation MetricsMultiples, price ratios, and targets
VHI4/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
VHI6/9
Total Returns1Y, 3Y, 5Y total returns with dividends
CC3/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
HUN1/1
Income & Cash Flow (Last 12 Months)
CC leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CC is the larger business by revenue, generating $5.8B annually — 3.1x KRO's $1.9B. VHI is the more profitable business, keeping -3.2% of every revenue dollar as net income compared to TROX's -12.3%. On growth, VHI holds the edge at +4.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | KROKronos Worldwide,… | TROXTronox Holdings p… | VHIValhi, Inc. | HUNHuntsman Corporat… | CCThe Chemours Comp… |
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.9B | $2.9B | $2.1B | $5.7B | $5.8B |
| EBITDAEarnings before interest/tax | -$9M | $166M | $21M | $160M | -$132M |
| Net IncomeAfter-tax profit | -$134M | -$359M | -$67M | -$324M | -$411M |
| Free Cash FlowCash after capex | $35M | -$139M | $30M | $135M | $198M |
| Gross MarginGross profit ÷ Revenue | +10.1% | +5.8% | +13.3% | +12.9% | +15.1% |
| Operating MarginEBIT ÷ Revenue | -3.1% | -4.8% | -1.4% | -1.0% | -0.8% |
| Net MarginNet income ÷ Revenue | -7.1% | -12.3% | -3.2% | -5.7% | -7.1% |
| FCF MarginFCF ÷ Revenue | +1.9% | -4.8% | +1.4% | +2.4% | +3.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.1% | +3.0% | +4.8% | +0.7% | +1.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -126.1% | +7.1% | -88.1% | -3.3% | -6.1% |
CC leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
VHI leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, VHI's 12.2x EV/EBITDA is more attractive than KRO's 40.7x.
| Metric | KROKronos Worldwide,… | TROXTronox Holdings p… | VHIValhi, Inc. | HUNHuntsman Corporat… | CCThe Chemours Comp… |
|---|---|---|---|---|---|
| Market CapShares × price | $811M | $1.3B | $412M | $2.6B | $3.4B |
| Enterprise ValueMkt cap + debt − cash | $1.4B | $4.7B | $801M | $4.9B | $7.3B |
| Trailing P/EPrice ÷ TTM EPS | -7.34x | -2.83x | -7.20x | -9.27x | -8.75x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 4.19x | — | 15.55x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 40.71x | 16.80x | 12.24x | 19.64x | 21.72x |
| Price / SalesMarket cap ÷ Revenue | 0.44x | 0.46x | 0.20x | 0.45x | 0.58x |
| Price / BookPrice ÷ Book value/share | 1.08x | 0.92x | 0.30x | 0.86x | 13.44x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 22.11x | 65.93x |
VHI leads this category, winning 4 of 6 comparable metrics.
Profitability & Efficiency
VHI leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
VHI delivers a -4.8% return on equity — every $100 of shareholder capital generates $-5 in annual profit, vs $-163 for CC. VHI carries lower financial leverage with a 0.45x debt-to-equity ratio, signaling a more conservative balance sheet compared to CC's 18.27x. On the Piotroski fundamental quality scale (0–9), KRO scores 5/9 vs HUN's 2/9, reflecting solid financial health.
| Metric | KROKronos Worldwide,… | TROXTronox Holdings p… | VHIValhi, Inc. | HUNHuntsman Corporat… | CCThe Chemours Comp… |
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -17.0% | -30.4% | -4.8% | -8.1% | -163.4% |
| ROA (TTM)Return on assets | -9.4% | -7.7% | -3.3% | -4.6% | -5.5% |
| ROICReturn on invested capital | -1.9% | -0.3% | -0.0% | -0.6% | -0.1% |
| ROCEReturn on capital employed | -2.2% | -0.4% | -0.0% | -0.7% | -0.1% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 2 | 4 | 2 | 4 |
| Debt / EquityFinancial leverage | 0.77x | 2.48x | 0.45x | 0.92x | 18.27x |
| Net DebtTotal debt minus cash | $540M | $3.4B | $389M | $2.3B | $3.9B |
| Cash & Equiv.Liquid assets | $37M | $211M | $223M | $429M | $672M |
| Total DebtShort + long-term debt | $577M | $3.6B | $612M | $2.7B | $4.6B |
| Interest CoverageEBIT ÷ Interest expense | -2.32x | -1.16x | -0.39x | -1.08x | 1.15x |
VHI leads this category, winning 6 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
CC leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CC five years ago would be worth $7,726 today (with dividends reinvested), compared to $4,493 for TROX. Over the past 12 months, CC leads with a +108.8% total return vs VHI's -16.0%. The 3-year compound annual growth rate (CAGR) favors VHI at 2.4% vs HUN's -12.6% — a key indicator of consistent wealth creation.
| Metric | KROKronos Worldwide,… | TROXTronox Holdings p… | VHIValhi, Inc. | HUNHuntsman Corporat… | CCThe Chemours Comp… |
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +58.5% | +98.1% | +20.3% | +45.5% | +83.6% |
| 1-Year ReturnPast 12 months | -1.2% | +76.9% | -16.0% | +37.5% | +108.8% |
| 3-Year ReturnCumulative with dividends | -0.7% | -23.6% | +7.3% | -33.3% | -15.7% |
| 5-Year ReturnCumulative with dividends | -43.9% | -55.1% | -46.5% | -39.8% | -22.7% |
| 10-Year ReturnCumulative with dividends | +129.0% | +116.1% | -2.7% | +57.6% | +219.7% |
| CAGR (3Y)Annualised 3-year return | -0.2% | -8.6% | +2.4% | -12.6% | -5.5% |
CC leads this category, winning 3 of 6 comparable metrics.
Risk & Volatility
Evenly matched — VHI and HUN each lead in 1 of 2 comparable metrics.
Risk & Volatility
VHI is the less volatile stock with a 1.06 beta — it tends to amplify market swings less than TROX's 2.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HUN currently trades 92.7% from its 52-week high vs VHI's 72.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | KROKronos Worldwide,… | TROXTronox Holdings p… | VHIValhi, Inc. | HUNHuntsman Corporat… | CCThe Chemours Comp… |
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.57x | 2.37x | 1.06x | 1.73x | 1.92x |
| 52-Week HighHighest price in past year | $7.90 | $10.59 | $20.00 | $15.89 | $28.67 |
| 52-Week LowLowest price in past year | $4.08 | $2.86 | $11.44 | $7.30 | $9.13 |
| % of 52W HighCurrent price vs 52-week peak | +89.2% | +79.4% | +72.8% | +92.7% | +78.1% |
| RSI (14)Momentum oscillator 0–100 | 63.4 | 58.5 | 54.0 | 65.4 | 48.1 |
| Avg Volume (50D)Average daily shares traded | 350K | 3.1M | 15K | 6.2M | 3.1M |
Evenly matched — VHI and HUN each lead in 1 of 2 comparable metrics.
Analyst Outlook
HUN leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: KRO as "Hold", TROX as "Buy", VHI as "Sell", HUN as "Hold", CC as "Hold". Consensus price targets imply -1.2% upside for CC (target: $22) vs -29.1% for KRO (target: $5). For income investors, HUN offers the higher dividend yield at 5.74% vs VHI's 2.19%.
| Metric | KROKronos Worldwide,… | TROXTronox Holdings p… | VHIValhi, Inc. | HUNHuntsman Corporat… | CCThe Chemours Comp… |
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Sell | Hold | Hold |
| Price TargetConsensus 12-month target | $5.00 | $7.25 | — | $12.00 | $22.14 |
| # AnalystsCovering analysts | 7 | 17 | 1 | 33 | 20 |
| Dividend YieldAnnual dividend ÷ price | +2.8% | +3.6% | +2.2% | +5.7% | +2.3% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 0 | 0 | 0 |
| Dividend / ShareAnnual DPS | $0.20 | $0.30 | $0.32 | $0.85 | $0.52 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | +0.1% | 0.0% |
HUN leads this category, winning 1 of 1 comparable metric.
Key Takeaway
CC leads in 2 of 6 categories (Income & Cash Flow, Total Returns). VHI leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.
Best OverallValhi, Inc. (VHI)Leads 2 of 6 categories
Loading custom metrics...
KRO vs TROX vs VHI vs HUN vs CC: Key Questions Answered
9 questions · data-driven answers · updated daily
01Is KRO or TROX or VHI or HUN or CC a better buy right now?
For growth investors, The Chemours Company (CC) is the stronger pick with 0.
4% revenue growth year-over-year, versus -5. 8% for Huntsman Corporation (HUN). Analysts rate Tronox Holdings plc (TROX) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — KRO or TROX or VHI or HUN or CC?
Over the past 5 years, The Chemours Company (CC) delivered a total return of -22.
7%, compared to -55. 1% for Tronox Holdings plc (TROX). Over 10 years, the gap is even starker: CC returned +219. 7% versus VHI's -2. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — KRO or TROX or VHI or HUN or CC?
By beta (market sensitivity over 5 years), Valhi, Inc.
(VHI) is the lower-risk stock at 1. 06β versus Tronox Holdings plc's 2. 37β — meaning TROX is approximately 123% more volatile than VHI relative to the S&P 500. On balance sheet safety, Valhi, Inc. (VHI) carries a lower debt/equity ratio of 45% versus 18% for The Chemours Company — giving it more financial flexibility in a downturn.
04Which is growing faster — KRO or TROX or VHI or HUN or CC?
By revenue growth (latest reported year), The Chemours Company (CC) is pulling ahead at 0.
4% versus -5. 8% for Huntsman Corporation (HUN). On earnings-per-share growth, the picture is similar: Huntsman Corporation grew EPS -44. 5% year-over-year, compared to -890. 0% for Tronox Holdings plc. Over a 3-year CAGR, KRO leads at -1. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — KRO or TROX or VHI or HUN or CC?
Valhi, Inc.
(VHI) is the more profitable company, earning -2. 8% net margin versus -16. 2% for Tronox Holdings plc — meaning it keeps -2. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VHI leads at -0. 0% versus -1. 7% for KRO. At the gross margin level — before operating expenses — CC leads at 15. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is KRO or TROX or VHI or HUN or CC more undervalued right now?
On forward earnings alone, Valhi, Inc.
(VHI) trades at 4. 2x forward P/E versus 15. 5x for The Chemours Company — 11. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CC: -1. 2% to $22. 14.
07Which pays a better dividend — KRO or TROX or VHI or HUN or CC?
All stocks in this comparison pay dividends.
Huntsman Corporation (HUN) offers the highest yield at 5. 7%, versus 2. 2% for Valhi, Inc. (VHI).
08Is KRO or TROX or VHI or HUN or CC better for a retirement portfolio?
For long-horizon retirement investors, Valhi, Inc.
(VHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 06), 2. 2% yield). Tronox Holdings plc (TROX) carries a higher beta of 2. 37 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VHI: -2. 7%, TROX: +116. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between KRO and TROX and VHI and HUN and CC?
Both stocks operate in the null sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: KRO is a small-cap quality compounder stock; TROX is a small-cap income-oriented stock; VHI is a small-cap quality compounder stock; HUN is a small-cap income-oriented stock; CC is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(KRO: 4.1% · TROX: 3.0%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.